- Harvard Business Review
Good Shepherd Pharmacy and RemediChain: Will this Blockchain Deliver Donated Drugs to Needy Patients
In May 2019 Memphis-based pharmacist and social entrepreneur Phil Baker hopes coding will start soon on blockchain software and related applications that will enable efficient and secure collection of usable drugs from individual donors and redistribution to needy authorized patients. To reach this point, he founded the subscription-based Good Shepherd charitable pharmacy, which bypasses pharmacy industry middlemen to sell medications at low prices, and distribute free donated drugs. Next, he successfully lobbied for passage of a Tennessee law that allows medications to be donated by individuals from anywhere in the US, to be redispensed to Tennessee patients, prioritized by need. After forming RemediChain LLC, recruiting a software development team, conducting some pilot tests to verify how to attract willing donors and needy patients, and launching the design phase for the blockchain system architecture, he formed a small consortium of pharmacy schools and other health-care organizations, in anticipation of further pilot-testing. Now, he wants to identify and plan how to mitigate foreseeable blockchain system project challenges before the system architecture and key elements are designed and software development begins. Since his two organizations (RemediChain LLC and Good Shepherd Pharmacy) are under financial pressure, and he wants to move forward quickly on building a scalable solution.